Sign Up
Stories
Meliora Therapeutics and AHA's Heart Health Initiatives
Share
Healthcare Industry Insights 2024
Healthcare Innovations and Insights
Healthtech Investor Insights and Expansi...
7wireVentures' $217M Health Fund Launch
AI-Powered Medical Education Platform La...
AIS Healthcare Honors Patient Care
Overview
API
Meliora Therapeutics appoints Claudio Chuaqui as CSO and Anand Selvaraj as Head of Cancer Biology, with a focus on machine learning therapeutics. The company has raised $11 million and is supported by high-quality international investors. The American Heart Association celebrates its 100th anniversary by advocating for heart and brain health and supporting healthy living.
Ask a question
How might the focus on machine learning therapeutics in Meliora Therapeutics impact the future of medical research and treatment?
In what ways can individuals contribute to supporting healthy living in their communities, as advocated by the American Heart Association?
What are some potential challenges the American Heart Association might face in achieving its goals of advocating for heart and brain health?
Article Frequency
0.2
0.4
0.6
0.8
1.0
Nov 2023
Dec 2023
Jan 2024
Feb 2024
Coverage
innov